Francisca Díaz‐González

Francisca Díaz‐González

Auto-generated profile, based on publicly available information

Francisca Díaz‐González

Institute of Medical and Molecular Genetics (INGEMM) Hospital Universitario La Paz, IdiPAZ Madrid Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
LSLucía Sentchordi-Montané
Lucía Sentchordi-Montané
SBSara Benito-Sanz
Sara Benito-Sanz
MAMiriam Aza-Carmona
Miriam Aza-Carmona
FDFrancisca Díaz-González
Francisca Díaz-González
SMSilvia Modamio-Høybjør
Silvia Modamio-Høybjør
KHKaren E. Heath
Karen E. Heath
Objective: Next generation sequencing (NGS) has expanded the diagnostic paradigm turning the focus to the growth plate. The aim of the study was to determine the prevalence of variants in genes implicated in skeletal dysplasias in probands with short stature and mild skeletal anomalies. Design: Clinical and radiological data were collected from 108 probands with short stature and mild skeletal anomalies. Methods: A customized skeletal dysplasia NGS panel was performed. Variants were classified using ACMG recommendations and Sherloc. Anthropometric measurements and skeletal anomalies were subsequently compared in those with or without an identified genetic defect. Results: Heterozygous variants were identified in 21/108 probands (19.4%). Variants were most frequently identified in ACAN (n = 10) and IHH (n = 7) whilst one variant was detected in COL2A1, CREBBP, EXT1, and PTPN11. Statistically significant differences (P < 0.05) were observed for sitting height/height (SH/H) ratio, SH/H ratio standard deviation score (SDS), and the SH/H ratio SDS >1 in those with an identified variant compared to those without. Conclusions: A molecular defect was elucidated in a fifth of patients. Thus, the prevalence of mild forms of skeletal dysplasias is relatively high in individuals with short stature and mild skeletal anomalies, with variants in ACAN and IHH accounting for 81% of the cases. An elevated SH/H ratio appears to be associated with a greater probability in detecting a variant, but no other clinical or radiological feature has been found determinant to finding a genetic cause. Currently, we cannot perform extensive molecular studies in all short stature individuals so detailed clinical and radiological phenotyping may orientate which are the candidate patients to obtain worthwhile results. In addition, detailed phenotyping of probands and family members will often aid variant classification.

1 January 2018 in Frontiers in Neuroendocrinology
Verified
Journal Article
Closed access
HPHelena Pinos
Helena Pinos
BCBeatriz Carrillo
Beatriz Carrillo
FDFrancisca Díaz
Francisca Díaz
JCJulie Ann Chowen
Julie Ann Chowen
Paloma Collado GuiraoPaloma Collado Guirao
Paloma Collado Guirao

15 November 2021 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
APAlistair T Pagnamenta
Alistair T Pagnamenta
FDFrancisca Diaz-Gonzalez
Francisca Diaz-Gonzalez
BBBenito Banos-Pinero
Benito Banos-Pinero
MFMatteo P Ferla
Matteo P Ferla
MTMehran B Toosi
Mehran B Toosi
JTJenny Taylor
Jenny Taylor

2 November 2020 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
LSLucia Sentchordi‐Montané
Lucia Sentchordi‐Montané
FDFrancisca Diaz‐Gonzalez
Francisca Diaz‐Gonzalez
ECElena V. Cátedra‐Vallés
Elena V. Cátedra‐Vallés
KHKaren E. Heath
Karen E. Heath

28 August 2020 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
ATAndré Travessa
André Travessa
FDFrancisca Díaz‐González
Francisca Díaz‐González
TMTeresa Mirco
Teresa Mirco
FOFilipa Oliveira‐Ramos
Filipa Oliveira‐Ramos
MPManuel Parrón‐Pajares
Manuel Parrón‐Pajares
ASAna Berta Sousa
Ana Berta Sousa

20 January 2014 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
MGMiriam Granado
Miriam Granado
FDF. Diaz
F. Diaz
EFE. Fuente-Martín
E. Fuente-Martín
CGCristina García-Cáceres
Cristina García-Cáceres
JAJesús Argente
Jesús Argente
JCJulie Ann Chowen
Julie Ann Chowen
Hyperleptinemia during postnatal life induces long-term effects on metabolism. However, these effects are controversial as both increased and decreased propensity towards obesity has been reported. To further analyze the effects of chronic neonatal hyperleptinemia on the subsequent metabolic profile, male Wistar rats proceeding from 18 different litters (8 pups/litter) received a daily subcutaneous injection of either saline (10 ml/kg, n=36) or leptin (3 μg/g, n=36) from postnatal day (PND) 2 to PND9. Rats were sacrificed at 10, 40, or 150 days of age. At 10 days of age, leptin treated rats had decreased body weight (p<0.001) and body fat (p<0.05). Leptin levels and glycemia were increased (p<0.01), whereas insulin, total lipids, triglycerides and glycerol levels were decreased (p<0.05). At PND40 rats receiving leptin had increased glycemia (p<0.01) and plasma HDL and LDL levels, but decreased total lipids (p<0.05). At PND150 neonatal leptin treatment induced different effects in rats raised in different litters. Rats from litter 1 had increased body weight (p<0.05), body fat (p<0.01), and plasma leptin (p<0.001), cholesterol (p<0.001), triglyceride (p<0.001), total lipid (p<0.001), LDL (p<0.05), and glycerol (p<0.001) levels. In rats from litter 2 these parameters did not differ from controls. Rats from litter 3 had decreased body weight (p<0.05), visceral fat (p<0.01) and plasma leptin (p<0.001), cholesterol (p<0.001), triglyceride (p<0.001), glycerol (p<0.001), and HDL (p<0.001) levels. In conclusion, the metabolic response to postnatal leptin varies with age, with the response in adulthood being variable and most likely influenced by other factors, including the genetic make-up.